R. Roberts, W. Rodriguez, D. Murphy, and T. Crescenzi, Pediatric Drug Labeling, JAMA, vol.290, issue.7, p.607
DOI : 10.1001/jama.290.7.905

B. J. Anderson, G. A. Woollard, and H. N. , A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children, British Journal of Clinical Pharmacology, vol.60, issue.2, pp.125-134, 2000.
DOI : 10.1046/j.1365-2125.2000.00231.x

M. Danhof and K. C. , Prediction of propofol clearance in children from an

B. J. Anderson, K. Allegaert, and H. N. , Population clinical pharmacology of children: modelling covariate effects, European Journal of Pediatrics, vol.42, issue.1, pp.819-829, 2006.
DOI : 10.1007/s00431-006-0189-x

B. J. Anderson and N. H. Holford, Tips and traps analyzing pediatric PK data, Pediatric Anesthesia, vol.11, issue.Suppl
DOI : 10.1111/j.1460-9592.2011.03536.x

M. Danhof and C. Knibbe, A neonatal amikacin covariate model can be used to 716 predict ontogeny of other drugs eliminated through glomerular filtration in neonates

J. Simpson, K. Jamsen, R. Price, N. White, N. Lindegardh et al., and Duffull 719 S. Towards optimal design of anti-malarial pharmacokinetic studies [38] The PopED development team. PopED manual. Documentation available at http: 722 Version 2.13, Malar. J, vol.720, issue.8, pp.189-196, 2009.

M. Dodds, A. Hooker, and P. Vicini, Robust Population Pharmacokinetic Experiment Design, Journal of Pharmacokinetics and Pharmacodynamics, vol.99, issue.1, pp.33-63, 2005.
DOI : 10.1007/s10928-005-2102-z

R. Laboratories, [Online; accessed 03, 728 Adults Children (N=77) (N=101) Weight, 2008.